VAERS Explorer
Back to explore

Report #2827983

Received Feb 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Feb 21, 2025
Onset
Feb 23, 2025
Days to onset
2
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURERUNKUNK—

Symptoms (1)

Nausea

Symptom narrative

Nausea; This non-serious case was reported by a consumer and described the occurrence of nausea in a 55-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concomitant products included fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (Trelegy). On 21-FEB-2025, the patient received Shingles vaccine. On 23-FEB-2025, 2 days after receiving Shingles vaccine, the patient experienced nausea (Verbatim: Nausea). The outcome of the nausea was not resolved. It was unknown if the reporter considered the nausea to be related to Shingles vaccine. It was unknown if the company considered the nausea to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 23-FEB-2025 The patient self-reported this case The patient received Shingles vaccine and experienced nausea and was not treated

Other medications

TRELEGY